XML 84 R53.htm IDEA: XBRL DOCUMENT v3.25.1
Stock–Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Unrecognized Compensation Expense

Unrecognized compensation expense related to the stock-based compensation awards and equity-based awards as of December 31, 2024 was as follows:

 

   As of December 31, 2024 
   Restricted Stock   Equity Plans   ABG Warrants   Totals 
Unrecognized compensation expense  $451   $1,015   $19   $1,485 
Weighted average period expected to be recognized (in years)   0.93    1.02    1.52    1.00 
Publisher Partner Warrant [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Warrants Activity

A summary of the Publisher Partner Warrants activity during the year ended December 31, 2024 is as follows:

 

           Weighted 
           Average 
       Weighted   Remaining 
   Number   Average   Contractual 
   of   Exercise   Life 
   Shares   Price   (in Years) 
Publisher Partner Warrants outstanding at January 1, 2024   9,800   $6.91    4.15 
Granted   -    6.91    3.15 
Publisher Partner Warrants outstanding at December 31, 2024   9,800    7.11    3.14 
Publisher Partner Warrants exercisable at December 31, 2024   6,062           
Publisher Partner Warrants not vested at December 31, 2024   3,738           
Publisher Partner Warrants available for future grants at December 31, 2024   23,200           
ABG Warrants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Warrants Activity

A summary of the ABG Warrant activity during the year ended December 31, 2024 is as follows:

 

   Number of Shares   Weighted Average   Weighted Average Remaining Contractual Life 
   Unvested   Vested   Exercise Price   (in years) 
ABG Warrants outstanding at January 1, 2024   599,724    399,816   $11.55    5.46 
Vested   (599,724)   599,724    -    - 
ABG Warrants outstanding at December 31, 2024   -    999,540    11.55    4.45 
Summary of Stock-based Compensation

Stock–based compensation and equity-based expense charged to operations or capitalized during the years ended December 31, 2024 and 2023 are summarized as follows:

 

   Year Ended December 31, 2024 
   Restricted Stock   Equity Plans   Warrants   Totals 
Cost of revenue  $119   $745   $13   $877 
Selling and marketing   20    187    -    207 
General and administrative   909    432    -    1,341 
Total costs charged to operations   1,048    1,364    13    2,425 
Capitalized platform development   -    259    -    259 
Total stock-based compensation  $1,048   $1,623   $13   $2,684 

 

 

   Year Ended December 31, 2023 
   Restricted Stock   Equity Plans   Warrants   Totals 
Cost of revenue  $2,092   $2,136   $10   $4,238 
Selling and marketing   257    961    -    1,218 
General and administrative   6,372    3,454    1,010    10,836 
Total costs charged to operations   8,721    6,551    1,020    16,292 
Capitalized platform development   -    1,016    -    1,016 
Total stock-based compensation  $8,721   $7,567   $1,020   $17,308 
Restricted Stock Units [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Restricted Stock Units Activity

A summary of the restricted stock unit activity during the year ended December 31, 2024 is as follows:

 

   Number of Shares   Weighted Average Grant-Date Fair 
   Unvested   Vested   Value 
Restricted stock units outstanding at January 1, 2024   199,267    612,871   $13.55 
Granted   222,396    -    1.55 
Vested   (366,491)   366,491    4.11 
Issuance of common stock for restricted stock units   -    (971,863)     
Cancelled   (39,615)   -    8.72 
Restricted stock units outstanding at December 31, 2024   15,557    7,499    6.99 
Common Equity Awards [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Fair Value of Stock Options Assumptions

 

   Years Ended December 31, 
   2024   2023 
   Up-list   Up-list 
Risk-free interest rate   3.85% - 3.98%   3.46% - 4.82%
Expected dividend yield   0.00%   0.00%
Expected volatility   47.32% - 47.35%   46.43% - 47.27%
Expected life   6 years    6 years 
Summary of Stock Option Activity

A summary of the common stock option activity during the year ended December 31, 2024 is as follows:

 

           Weighted 
           Average 
       Weighted   Remaining 
   Number   Average   Contractual 
   of   Exercise   Life 
   Shares   Price   (in Years) 
Common stock options outstanding at January 1, 2024   5,451,968   $9.56    4.43 
Granted   22,843    0.35      
Forfeited   (401,489)   7.58      
Expired   (2,129,646)   9.20      
Common stock options outstanding at December 31, 2024   2,943,676    10.03    2.98 
Common stock options exercisable at December 31, 2024   2,265,249    10.06    3.72 
Common stock options not vested at December 31, 2024   678,427           
Common stock options available for future grants at December 31, 2024 (1)   1,338,225           

 

(1)Common stock available for future issuance under the 2022 Plan represent 1,800,000 of authorized shares; less 422,052 common stock options outstanding and 19,723 restricted stock units outstanding.